Zobrazeno 1 - 10
of 37
pro vyhledávání: '"F. Montero Gei"'
Autor:
A. Perera, F. Montero-Gei
Publikováno v:
Clinical Infectious Diseases. 14:S77-S81
We treated 20 patients who had tinea corporis and/or tinea cruris and 20 patients who had tinea pedis with oral fluconazole. All patients were given a single 150-mg dose of fluconazole upon entry into the study; at that time, and at each follow-up vi
Publikováno v:
International journal of dermatology. 38(8)
Autor:
F, Montero-Gei
Publikováno v:
International journal of dermatology. 37(11)
Autor:
D A, Stevens, M, Diaz, R, Negroni, F, Montero-Gei, L G, Castro, S A, Sampaio, D, Borelli, A, Restrepo, L, Franco, J L, Bran, E G, Arathoon
Publikováno v:
Chemotherapy. 43(5)
The possible adverse effects of chronic, high-dose fluconazole therapy are detailed from analysis of a multicenter, dose-escalating study of the therapy of invasive mycoses. Ninety-three adult patients were studied, 48 of these receivedor = 6 months
Autor:
F, Montero-Gei
Publikováno v:
Archives of medical research. 24(4)
Fluconazole is a new systemic azole antifungal agent, with the imidazole group substituted by a triazole, presenting a decrease in lipophilicity, soluble in water, weakly bound to plasma proteins, and a wide range of formulations. The time to reach s
Publikováno v:
Clinical and experimental dermatology. 17(6)
Seventy adult out-patients with tinea pedis participated in a multicentre open non-comparative study of the safety and efficacy of once-weekly doses of oral fluconazole 150 mg. A mean of 3 doses of fluconazole was administered; patients infected with
Autor:
M, Diaz, R, Negroni, F, Montero-Gei, L G, Castro, S A, Sampaio, D, Borelli, A, Restrepo, L, Franco, J L, Bran, E G, Arathoon
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 14
Eighty-eight immunocompetent patients with deep mycoses from eight countries were evaluated with the same protocol for efficacy of fluconazole monotherapy. Entry doses were raised from 100 to 400 mg as safety was shown in initial cohorts, and dosages
Autor:
F. Montero-Gei
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 11:S105
Publikováno v:
Medicina cutanea ibero-latino-americana. 11(6)
The results of the treatment of 30 cases of chromomycosis (fonsecal pedrosoi) with Thiabendazole (1 g.) and 5. Fluorocytosine (4 g.) are reported. The medium rate of healing was 7,63 months. This treatment was effective in 25 of 30 cases (83 por 100)
Autor:
M, Chinchilla, F, Montero-Gei
Publikováno v:
Revista latinoamericana de microbiologia. 12(1)